VisionPoint Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Buy
+2,585
New +$231K 0.04% 390
2024
Q3
Sell
-239
Closed -$14.1K 357
2024
Q2
$14.1K Sell
239
-72
-23% -$4.5K 0.01% 454
2024
Q1
$24.8K Sell
311
-9
-3% -$687 0.01% 361
2023
Q4
$25.3K Sell
320
-1,284
-80% -$91.4K 0.01% 332
2023
Q3
$112K Buy
1,604
+1,338
+503% +$94.8K 0.05% 180
2023
Q2
$18.4K Buy
+266
New +$18.9K 0.01% 297
2020
Q1
Sell
-4,180
Closed -$311K 124
2019
Q4
$311K Buy
4,180
+90
+2% +$6.32K 0.13% 86
2019
Q3
$255K Buy
4,090
+78
+2% +$4.62K 0.07% 115
2019
Q2
$219K Buy
+4,012
New +$216K 0.06% 123

Other funds holding CVS

VisionPoint Advisory Group's CVS Position: Q2 2026 in Review

VisionPoint Advisory Group opened a new position in CVS Health (CVS) in Q2 2026: 2,585 shares worth $267K. The stake represents 0.04% of the portfolio and ranks #390 among its holdings. This is a return to the name: VisionPoint Advisory Group previously reported a position in CVS as recently as Q2 2024.

VisionPoint Advisory Group first reported a position in CVS in Q2 2019 and has held it in 9 quarters since. The position peaked at $311K in Q4 2019. 348 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • VisionPoint Advisory Group held 2,585 shares of CVS Health worth $267K as of Q2 2026.
  • CVS Health was a new VisionPoint Advisory Group position in Q2 2026.
  • CVS Health made up 0.04% of VisionPoint Advisory Group's portfolio in Q2 2026, its #390 holding.
  • VisionPoint Advisory Group first reported a position in CVS Health in Q2 2019 and has held it in 9 quarters since.
  • VisionPoint Advisory Group's CVS Health position peaked at $311K in Q4 2019.
  • 348 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.